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Selenium is an essential micronutrient. Its recommended daily allowance is not attained by a
significant proportion of the population in many countries and its intake has been suggested to
affect colorectal carcinogenesis. Therefore, microarrays were used to determine how both sele-
noprotein and global gene expression patterns in the mouse colon were affected by marginal
selenium deficiency comparable to variations in human dietary intakes. Two groups of 12 mice
each were fed a selenium-deficient (0.086 mg Se/kg) or a selenium-adequate (0.15 mg Se/kg)
diet. After 6 wk, plasma selenium level, liver, and colon glutathione peroxidase (GPx) activity in
the deficient group was 12, 34, and 50%, respectively, of that of the adequate group. Differential
gene expression was analysed with mouse 44K whole genome microarrays. Pathway analysis by
GenMAPP identified the protein biosynthesis pathway as most significantly affected, followed by
inflammation, Delta-Notch and Wnt pathways. Selected gene expression changes were
confirmed by quantitative real-time PCR. GPx1 and the selenoproteins W, H, and M, responded
significantly to selenium intake making them candidates as biomarkers for selenium status.
Thus, feeding a marginal selenium-deficient diet resulted in distinct changes in global gene
expression in the mouse colon. Modulation of cancer-related pathways may contribute to the
higher susceptibility to colon carcinogenesis in low selenium status.
Keywords:
Cancer / Microarrays / Selenium / Selenoproteins / Wnt signalling
1 Introduction
The current recommended daily intake for the essential
micronutrient selenium ranges between 40 mg/day (WHO)
and 85 mg/day (Australia) for adult males, depending on the
country; the value for females is normally 10 mg less [1].
These intakes are not achieved in many countries [1] and
sub-optimal selenium intake may have impact on immune
function and susceptibility to viral disease and cancers [2].
Both observational and intervention studies suggest that a
low selenium status is inversely correlated with an increased
colorectal cancer incidence [3–5]. Furthermore, results of the
Nutritional Prevention of Cancer Trial in USA indicated that
a daily supplement of 200mg Se reduced mortality from
colorectal cancer [6].
Abbreviations: Dvl, dishevelled; FC, fold change; FDR, False
discovery rate; Sec, selenocysteine; qPCR, quantitative real-time
PCR These authors contributed equally to this work
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Selenium is incorporated into selenoproteins as seleno-
cysteine (Sec). In humans, 25 selenoprotein-encoding genes
have been identified, whereas the number is 24 in mice [7].
Selenoprotein levels respond differently to selenium
deficiency, a phenomenon called the ‘‘hierarchy of seleno-
proteins’’. Glutathione peroxidase-1 (GPx1) is considered
to rank lowest in this hierarchy, since it rapidly declines
upon selenium deprivation and is re-synthesized with
considerable delay upon selenium repletion [8, 9].
Others, such as GPx4, GPx2, deiodinases, or thioredoxin
reductases rank high in the hierarchy. In general, the
ranking of selenoproteins parallels the stability of the
pertinent mRNA. However, the ranking of all selenopro-
teins is not known so far, mainly due to lack of both
systematic feeding experiments and data on the response of
all selenoproteins.
Selenium intake also affects expression of non-seleno-
proteins. Organo-selenium compounds increase the
expression of phase II enzymes and pro-apoptotic genes and
decrease expression of genes regulating cell growth [10, 11].
In mice, stress response, cell cycle/growth control, and
angiogenesis/cell adhesion genes are affected by severe
selenium deficiency [12]. Xenobiotic metabolizing enzymes
are modulated by selenium deficiency [13] via the activation
of Nrf2 and Nrf2-independent pathways [14]. Thus, either
supranutritional selenium intake or forms of selenium not
usually present in the diet alter the expression of a range of
non-selenoprotein genes. In addition, nutritionally relevant
amounts of selenium have been shown recently to increase
expression of protein biosynthesis genes in lymphocytes of
human volunteers [15].
Since selenium intake has been implicated in colon
carcinogenesis [6], this study used microarray and quanti-
tative real-time PCR (qPCR) analysis of the mouse colon to
identify both selenoproteins and novel targets affected by a
selenium depletion comparable to those found in humans.
We focussed on the colon because it is one of the organs in
which selenium status affects development of cancer [6].
Levels of SelW, GPx1, SelH, and SelM mRNAs were down-
regulated in selenium deficiency. Non-selenoprotein path-
ways were also affected, notably those involved in protein
biosynthesis, inflammatory pathways, and Wnt signalling,
which might contribute to higher cancer risk in selenium
deficiency.
2 Materials and methods
2.1 Animals, feeding protocol, and sampling
The animal study was approved by the Governmental
Animal Ethics Committee (MLUV 32-44457141). Male
C57BL/6J mice (3–4 wk of age) from Charles River (Sulzfeld,
Germany) were randomly assigned to the selenium-deficient
or selenium-adequate group (12 mice per group) with free
access to food and water. The selenium-adequate diet was
produced by mixing selenomethionine (Acros, Geel,
Belgium) into the selenium-deficient diet (No. C1045 with
50% carbohydrates, 17% protein, 5% fat, 4% fibre, and
mixture of micronutrients; Altromin, Lage, Germany)
containing 0.086 mg Se/kg [16] to yield a selenium content
of 0.15 mg/kg corresponding to the dietary reference intake
for mice [17]. Diets were fed as powder for 6 wk until mice
were killed in the non-fasted state. Animals were anesthe-
tized with isofluran and blood was withdrawn from the
retro-orbital plexus. Anesthetized animals were killed by
cervical dislocation. Plasma and tissues freeze clamped in
liquid nitrogen were stored at 801C.
2.2 RNA isolation
Colon tissue was ground under liquid nitrogen. In total,
20–30 mg powder were suspended in 800mL of cold Trizol
(Invitrogen, Karlsruhe, Germany), homogenized with a tissue
lyzer (Qiagen, Hilden, Germany), and RNA isolated using the
Trizol protocol and RNeasy mini columns (Qiagen). RNA
quality was checked using a Bioanalyzer 2100 (Agilent Tech-
nologies, Böblingen, Germany). RNA samples subsequently
used for microarray analysis had a RIN-number Z9.0.
2.3 Microarray analysis
Differential gene expression was analysed using one RNA
sample per mouse 44K microarray (Agilent Technologies) [18].
Briefly, the microarray (G4122A) contains 41 000 probes that
cover all known genes in the mouse genome and the primary
resulting transcripts. A total of 500 ng RNA was subjected to
cDNA synthesis and subsequent cRNA amplification and
labelling, using the Agilent Low RNA Input Fluorescent Linear
Amplification Kit. Each cDNA sample was split in two
aliquots: one (sample) was labelled with Cyanine 5-CTP (Cy5),
the other (reference) with Cyanine 3-CTP (Cy3). Cy5 and Cy3
were obtained from PerkinElmer (Boston, MA, USA).
Cy-labelled cRNAs were purified using RNeasy mini columns
(Qiagen). A reference pool was generated with equimolar
amounts of each Cy3-labelled cRNA. Hybridization of 1mg
Cy5-labelled sample cRNA and 1mg of the Cy3-labelled
reference pool cRNA and subsequent washing were performed
by following the Agilent hybridization procedure with modi-
fications [18]. Microarrays were scanned with a Scanarray
Express HT scanner (PerkinElmer) and signal intensity
of each spot determined with ArrayVision 8.0 (Imaging
Research, Ont., Canada). Per spot signal over background
intensity was calculated per array for both channels and
each averaged over all arrays; those with a threshold above 2.0
were processed further. Raw data quality of the microarrays
was assessed using the software ‘‘R’’ [19] and Microsoft
Excel (Microsoft, Redwood, Maryland, MD, USA), based on
intensity ratios (M) against the average intensity (A) plots
(MA plots), scatter plots, and NP plots (sample size n times the
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proportion of non-forming items P). All arrays passed.
Subsequently, data were normalized [20] using GeneMaths XT
1.6 (Applied Maths, Sint-Martens-Latem, Belgium). False
discovery rate (FDR) analysis at a cut-off of 5% was carried out
according to the Benjamini–Hochberg procedure [21]. Signif-
icantly, regulated genes were also identified with Student’s
t-test (po0.05).
2.4 Pathway analysis
Probes were annotated to UniProt and Ensembl IDs to make
them compatible with the program GenMAPP (Gene Map
Annotator and Pathway Profiler) [22] that was used for
pathway analysis. Pathways were selected using the
MAPPFinder based on the amount of regulated genes
present [23]. Genes were considered to be regulated when
meeting the criterion: absolute fold change (FC) Z1.2 and
p-value r0.05. An FC of 1.2 was chosen not to overlook
small changes caused by dietary intervention and more
importantly to find multiple altered genes in one pathway
reflecting its physiological relevance [24]. Per pathway
z-score was calculated [23].
2.5 qPCR
RNA (3mg) was reversely transcribed with 150 fmol
oligo(dT)15 primers and 180 U moloney murine leukemia
virus reverse transcriptase (Promega, Mannheim, Germany) in
a total volume of 45mL. qPCRs (Mx3005PTM qPCR System,
Stratagene, Amsterdam, Netherlands) were performed in
triplicates with 1mL of tenfold diluted cDNA in 25mL reaction
mixtures using SYBR Green I (Molecular Probes, Eugene, OR,
USA) as fluorescent reporter. PCR products were quantified
with a standard curve. Primers (Table 1) were designed to be
specific for cDNA with PerlPrimer v1.1.14 [25]. Hprt and
Rpl13a were used as reference genes based on criteria: least
variation in microarray data between all samples (%CVo5%),
mean expression level ratio of deficient over adequate group
close to 1, and an expression level of at least ten times the
background. The mean of reference genes was used for
normalization [26].
2.6 PCR arrays
Mouse Wnt Signaling Pathway RT2 ProfilerTM PCR Arrays
and RT2 Real-Timer SyBR Green/ROX qPCR Master
Mix were purchased from SuperArray Bioscience (Frederick,
MD, USA). cDNA of the selenium-deficient and -adequate
group was pooled to equal amounts to provide two
samples for PCR array analysis. Raw data of 84 analyzed
genes were normalized and analysed by the RT2 ProfilerTM
PCR Array Data Analysis Web Portal using the DDCt
method.
2.7 Liver GPx activity and plasma selenium content
In total, 20 mg of tissue powder were homogenized in 500mL
100 mM Tris/HCl, 300 mM KCl, 0.1% Triton X-100, pH 7.6,
containing 4mL of protease inhibitor cocktail (Calbiochem,
Bad Soden, Germany). Cellular debris was removed at
20 000 g, 15 min, 41C. Protein content was estimated
according to Bradford [27]. GPx activity was measured in the
glutathione reductase-coupled test optimized for mouse tissue
[28] and expressed as mU/mg protein. The amount of plasma
selenium was measured fluorimetrically as described [29] and
modified previously [30].
2.8 Statistics
Student’s t-test was used to compare differences between
group (12 animals each) means. po0.05 was considered
significant. Statistical analysis was performed using
GraphPad Prism version 5 (La Jolla, San Diego, CA, USA).
3 Results
3.1 Plasma selenium concentration and liver GPx
activity
Plasma selenium in mice fed the selenium-deficient diet
was significantly lower than in those on selenium-adequate
diet (Fig. 1A) indicating the success of the feeding. The
plasma concentrations observed here were consistent with
the previous study [16]. GPx activity, a classical functional
marker of Se status, was about one-third of the adequate
group in the liver and half in the colon of Se-deficient mice
(Figs. 1B and C, respectively). Maximal differences between
feeding groups were usually reached after 5 wk and did not
further change after 6 wk. Food intake, weight gain, and
behaviour were unaffected by the diets with different sele-
nium contents. Histological monitoring of the colons did
not show any changes in cell pattern in selenium deficiency.
Especially, no infiltration of inflammatory cells was
observed (data not shown). Thus, any change in gene
expression described in the following does not result from a
change in composition of colon cells.
3.2 Selenium-responsive genes
Colon RNA samples from 12 selenium-deficient and 12
selenium-adequate mice individually hybridized to whole
genome microarrays yielded a total of 21 008 transcripts
(13 656 unique and annotated genes) with levels twice above
background and were used for subsequent data analyses.
Mean gene expression ratios of selenium-deficient and sele-
nium-adequate samples were calculated. By using an FDR
r5% a total of 952 genes (722 down- and 230 up-regulated in
Mol. Nutr. Food Res. 2009, 53, 1561–1572 1563
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Table 1. Primer sequences (50-30)
Gene Acc. Number Primer sequence Product size (bp)
14-3-3 (Ywhaq) NM_011739 fwd CACGGTCCTGGAATTGTTGG 125
rev ATCGCCACAAGCTACTTCAGC
b-Catenin NM_007614.2 fwd AGCTGGCCTGGTTTGATACTGAC 130
rev CTAAAACCATTCCCACCCTACCAA
c-Myc NM_010849.4 fwd AATCCTGTACCTCGTCCGATTCC 150
rev TCTTGCTCTTCTTCAGAGTCGCT
Dio 1 NM_007860 fwd GGGATTTCATTCAAGGCAGCAGG 115
rev TGTGGAGGCAAAGTCATCTACGA
Dvl2 NM_007888.3 fwd GGTTGTCTCCTGGCTTGTGTC 135
rev CCCAATTCCACTGGTCCTTTCTG
GPx1 NM_008160 fwd GAAGAGATTCTGAATTCCCTCAA 256
rev CACACCAGGAGAATGGCAAGA
GPx2 NM_030677 fwd GTGCTGATTGAGAATGTGGC 252
rev AGGATGCTCGTTCTGCCCA
GPx3 NM_001083929 fwd CCATTTGGCTTGGTCATTCTGGG 105
rev CACCTGGTCGAACATACTTGAGAC
GPx4 NM_001037741 fwd GCTGGGAAATGCCATCAAATGGA 115
rev ACGGCAGGTCCTTCTCTATCAC
Gsk3b NM_19827 fwd ATCAGCTGTTCAGAAGTCTAGCCT 132
rev AGCTGCTTTGCACTTCCAAAGTC
Hmox1 (heme oxygenase-1) NM_010442.1 fwd CCTGGTGCAAGATACTGCCC 105
rev GAAGCTGAGAGTGAGGACCCA
Lef1 NM_010703.3 fwd CCGAGATCAGTCATCCCGAAGAG 109
rev TTGTCTGACCACCTCATGCCC
Nqo1 NM_008706.4 fwd ATGTACGACAACGGTCCTTTCCAG 134
rev GATGCCACTCTGAATCGGCCA
Selenoprotein H NM_001037279 fwd CCTTATTCCACCAACGCGCCA 154
rev GCGTCAGCTCGTACAATGCTC
Selenoprotein I NM_027652 fwd ACTGGTTACTGCTTCCTCTCCTC 145
rev CTGCTTCACCACTTGTACGCC
Selenoprotein K NM_019979 fwd ATGGAAGAGGGCCACCAGGA 100
rev TTACCTTCCTCATCCACCAGCC
Selenoprotein M NM_053267 fwd GGACATTCAACTGTACCACAACCT 158
rev TAGAAGCCGAGCTCCTGTACCA
Selenoprotein O NM_027905 fwd TGACACTGAGTTCCAAAGGCAC 138
rev GTTAGTGAAGTCAGCACCAGTCAG
Selenoprotein P NM_001042613 fwd CTCATCTATGACAGATGTGGCCGT 137
rev AAGACTCGTGAGATTGCAGTTTCC
Selenoprotein S NM_024439.3 fwd GAAGGCCTCAGGAAGAAGATGGT 137
rev GTCTCCAGGAGCAGGTTCCA
Selenoprotein T NM_001040396 fwd CTTTAAATGATGTGCCAGTGTGGT 140
rev GGTAGGGCTATGATCGATGATGTG
Selenoprotein W NM_009156 fwd ATGCCTGGACATTTGTGGCGA 152
rev GCAGCTTTGATGGCGGTCAC
Selenoprotein X NM_013759 fwd ACTTCGAGCCAGGTGTCTACG 129
rev GGCACTTGGTCACACTGTCTG
Sep15 NM_053102 fwd GTTTCAAGCGGCGTCTGCTC 159
rev TGCTTCTTCCTGACAGCACCC
Sephs2 NM_009266.3 fwd CAAGTACGGAGAGGGTCACCA 148
rev CGTTGGAATTATCAGGAGCAGCAG
Smad4 NM_008540 fwd CACACCTAATTTGCCTCACCACC 136
rev ACTCAGGAGCAGGATGATTGGA
Stat3 NM_213659 fwd AAAGGACATCAGTGGCAAGACCC 112
rev TCGCATCCATGATCTTATAGCCCA
Tle2 NM_019725.1 fwd CTGGATTGCCTGAACCGAGAC 137
rev CTCTGCTTTGATCCGTGGTGTG
Trspap1 NM_027925.3 fwd AGCACCATGCAGACATATGAAGAG 134
rev GTGACAGTCCATCAGAGCATCGT
Txnrd 1 NM_015762.1 fwd TACTGCATCAGCAGTGATGATC 206
rev CCATGTTCTTCCATGTGTTCAC
1564 A. Kipp et al. Mol. Nutr. Food Res. 2009, 53, 1561–1572
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selenium deficiency) were identified. Using a less stringent
criterium, p-value of r0.05, 3995 genes (1979 down- and 2016
up-regulated in selenium deficiency) were identified. This
number clearly exceeds the number you might expect by
chance (5% would be 1050 genes).
A complete list of 20 selenoprotein genes being expressed
in the mouse colon is given in Table 2. Four selenoprotein
genes were significantly lower expressed in selenium-deficient
mice: Selw, Gpx1, Selh, and Selm. The remaining four known
murine selenoprotein genes Dio2, Dio3, Seln, and Selv were
not expressed at detectable levels in any dietary group.
To confirm the array data, qPCR was performed for all
selenoprotein genes (Table 2). Significantly, lower expression
after the marginal selenium-deficient diet was confirmed for
Selw, Gpx1, Selh, and Selm. Expression of Gpx3, Selk, Sels,
Txnrd1, Sep15, and Selt significantly responded to selenium
supply, which was not obvious from the array data. Similarly,
a small increase in the expression of Txnrd2 and Txnrd3 was
observed in qPCR but not in arrays. qPCR showed expression
levels of Gpx2, Sephs2, Sepp1, Seli, Dio1, Sepx1, Selo, and Gpx4
to be unaffected by Se intake, as observed in microarrays.
Thus, qPCR confirmed the major changes observed by
microarray analysis. The gene for tRNA Sec-associated protein
1 (Trspap1, also known as Secp43), a factor required for sele-
noprotein synthesis [31], was slightly, but significantly,
decreased in Se-deficient mice according to microarrays (FC:
0.84; p-value: 0.017) and qPCR (Fig. 2A).
3.3 Selenium-responsive pathways
Pathways were analyzed using GenMAPP. The data set
consisted of 41 441 probes of which 28 208 were annotated
to UniProt- and Ensembl-IDs. In total, 6536 genes of
these 28 208 probes were linked to murine pathways
present in GenMAPP (Table 3). A total of 2294 genes were
regulated according to the criteria: absolute FCZ1.2 and
p-valuer0.05. Based on these regulated genes and the total
amount of 6536 genes, pathways influenced by selenium
intake were ranked by the z-score (see Section 2). Five of the
top 15 pathways (translation factors, mRNA processing/
binding, mTOR signalling pathway, regulation of eIF4e-
and-p70-S6-Kinase, ribosomal proteins) are related to
protein biosynthesis (Table 3). A complete list of genes
regulated in protein biosynthesis pathways is provided in
Supporting Information Table S1.
The remaining ten regulated pathways comprised stress
response and regulatory phenomena, in particular related to
inflammation (TNFa-NFkB, IL-2, IL-3) and carcinogenesis
(Alpha6-Beta4-Integrin, Delta-Notch). These pathways
contained one or more of the genes for Smad4, Stat3, Ywhaq
(tyrosine 3-monooxygenase/tryptophan 5-monooxygenase
activation protein y, also called 14-3-3 y), and glycogen
synthase kinase 3b (GSK3b). Due to their multiple appear-
ances, these genes were selected for and confirmed by qPCR
(Figs. 2B–D and Fig. 3B).
Txnrd 2 NM_013711.3 fwd TACAGCAATGTTCCCACAACTGTC 148
rev CTATCCGCCACCGTGAACTC
Txnrd 3 NM_153162.3 fwd TCGACAACGAACGTGTGGTGG 111
rev AGTAGCTGCTTCGTGAGCCC
Reference genes
Hypoxanthine phosphoribosyl NM_013556 fwd GCAGTCCCAGCGTCGTG
transferase (Hprt1) rev GGCCTCCCATCTCCTTCAT 168
Ribosomal protein L13a (Rpl13a) NM_009438 fwd GTTCGGCTGAAGCCTACCAG
rev TTCCGTAACCTCAAGATCTGCT 157
Figure 1. Plasma selenium
concentration (A), liver (B),
and colon (C) GPx activity in
selenium-deficient and sele-
nium-adequate mice. Values
are means of 12 animals per
group (five animals in case
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Although the Wnt pathway was not within the top 15
pathways, it also showed a reasonably high z-score.
However, a high number of genes in the Wnt pathway were
classified as ‘‘not expressed’’ in the arrays and therefore this
pathway was further analysed by comparing two pools of
samples in a Wnt PCR array. In total, 37 genes responded to
lowering the selenium status with an absolute FCZ1.2,
however, only 25 were expressed at a level that could be
measured with sufficient sensitivity (cT-valueo30, Table 4).
Seven of these 25 genes were also significantly regulated
when analysed in microarrays (microarray FC and p-value,
Table 4). In total, 18 genes were ‘‘not expressed’’ in the
microarray from which six are still in the table due to a
distinct response in the PCR array. Changes in the expres-
sion of genes for b-catenin, GSK3b, dishevelled (Dvl),
lymphocyte enhancer factor-1 (Lef1), transducin-like
enhancer of split-2 (Tle2), and c-Myc as target of b-catenin
were confirmed by qPCR (Fig. 3A–F).
4 Discussion
The aim of this study was to analyse not only the expression
of selenoprotein genes but also the global expression
patterns in the colon, an organ that responds to the avail-
ability of selenium. In contrast to most earlier studies
relating gene expression to selenium status, animals were
fed a selenium-adequate and a marginally deficient diet, the
latter containing about half of the selenium considered to be
adequate for mice [17, 32]. The selenium intake, thus,
Figure 2. mRNA expression of non-selenoproteins in the colon of
selenium-deficient relative to selenium-adequate mice. (A) tRNA
Sec-associated protein (Trspap or Secp43), (B) Smad4, and (C)
Stat3, (D) 14-3-3 y (Ywhaq). Gene expression was analysed in
triplicate by qPCR and normalized to the mean of the reference
genes Hprt1 and Rpl13a. Values are means of 12 animals per
group7SD. po0.01 and po0.001 using Student’s t-test.
Table 3. Pathways in which genes were regulated by selenium supply ranked by z-score
MAPP Name Down Up z-score
Mm_Translation_Factorsa) 86 55 8.63
Mm_mRNA_processing_bindingb) 217 104 8.23
Mm_mTOR-Signaling-Pathwayc) 55 44 8.23
Mm_TNF-a-NF-kBd) 165 88 8.06
Mm_Regulation-of-eIF4e-and-p70-S6-Kinasec) 56 39 7.95
Mm_Ribosomal_Proteins 6 27 7.15
Mm_Proteasome_Degradationa) 98 49 7.09
Mm_ADP-Ribosylation-Factorc) 53 22 7.09
Mm_Gene-Expressionb) 78 58 7.02
Mm_Phosphoinositides-and-their-downstream-targetsc) 51 22 6.47
Mm_IL-2d) 68 36 6.36
Mm_IL-3d) 80 38 6.26
Mm_Insulin_Signalinga) 91 34 6.23
Mm_a6-b4-Integrind) 61 34 6.22
Mm_Delta-Notchd) 93 23 6.19
Mm_WNT-Signaling-Pathwayc) 73 13 4.37
Mm_Wntd) 105 28 4.02
Up and down indicate the number of genes which are up- or down-regulated in the respective pathway by selenium deficiency.
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reflects situations attained by common variation in the
human diet. The selenium status reached after 6 wk feeding
of these diets is characterized by a drop of plasma selenium
to 12%, and liver and colon GPx activity to 34 and 50%,
respectively. The decrease, thus, corresponds to a real defi-
ciency and is more severe than expected. Whether a constant
reduction in the intake of selenium leads to the same defi-
ciency in humans is not known. Definitely plasma selenium
Figure 3. mRNA expression of
non-selenoproteins involved in
the Wnt pathway in the colon of
selenium-deficient relative to
selenium-adequate mice. (A)
b-catenin, (B) glycogen synthase
kinase 3b (Gsk3b), (C) Dvl2, (D)
lymphocyte-enhancing factor-1
(Lef1), (E) transducin-like
enhancer of split 2 (Tle2), and
(F) c-Myc. Gene expression
was analysed in triplicate
by qPCR and normalized
to the mean of the reference
genes Hprt1 and Rpl13a.




Table 4. Genes of the Wnt pathway changed in the colon of Se-deficient mice as identified in the microarray and/or the PCR array
Gene name Agilent ID Description Acc. number Microarray FC
and (p-value)
PCR array FC
Ctnnb1 A_51_P272046 Catenin (cadherin associated protein), b1 NM_007614 0.84 (0.119) 1.28
Dixdc1 A_51_P468876 DIX domain containing 1 NM_178118 1.21 (0.011) 1.38
Dvl1 A_52_P234958 Dishevelled, dsh homolog 1 (Drosophila) NM_010091 1.12 (0.173) 1.32
Dvl2 A_51_P113106 Dishevelled 2, dsh homolog (Drosophila) NM_007888 n.d. 1.96
Ep300 A_52_P411601 E1A binding protein p300 NM_177821 0.98 (0.712) 1.30
Fbxw11 A_51_P141860 F-box and WD-40 domain protein 11 NM_134015 1.42 (0.038) 1.33
Fzd1 A_52_P597634 Frizzled homolog 1 (Drosophila) NM_021457 1.03 (0.751) 1.73
Fzd3 A_51_P190863 Frizzled homolog 3 (Drosophila) NM_021458 1.27 (0.148) 1.42
Fzd8 A_51P312517 Frizzled homolog 8 (Drosophila) NM_008058 n.d. 1.45
Gsk3b A_52_P641629 Glycogen synthase kinase 3b NM_019827 0.75 (5,4105) 1.06
Lef1 A_51_P420400 Lymphoid enhancer binding factor 1 NM_010703 n.d. 5.74
Lrp6 A_51_P169401 Low density lipoprotein receptor-related protein 6 NM_008514 n.d. 1.35
Myc A_52_P278549 Myelocytomatosis oncogene NM_010849 1.07 (0.267) 1.20
Nxn A_52_P57013 Nucleoredoxin NM_008750 1.20 (0.018) 1.14
Pitx2 A_52_P57013 Paired-like homeodomain transcription factor 2 NM_011098 1.31 (0.152) 1.68
Rhou A_51_P227392 Ras homolog gene family, member U NM_133955 1.12 (0.154) 1.36
Senp2 A_51_P492141 SUMO/sentrin specific peptidase 2 NM_029457 0.87 (0.015) 1.31
Sfrp2 A_51_P520849 Secreted frizzled-related protein 2 NM_009144 1.10 (0.163) 1.32
Sfrp4 A_51_P457196 Secreted frizzled-related protein 4 NM_016687 n.d. 0.59
Tle2 A_51_P175303 Transducin-like enhancer of split 2 NM_019725 1.13 (0.032) 0.30
Wif1 A_51_P484526 Wnt inhibitory factor 1 NM_011915 1.08 (0.180) 0.76
Wisp1 A_51_P220343 WNT1 inducible signaling pathway protein 1 NM_018865 1.21 (0.005) 1.37
Wnt4 A_51_P130475 Wingless-related MMTV integration site 4 NM_009523 n.d. 0.65
Wnt5b A_51_P137991 Wingless-related MMTV integration site 5B NM_009525 1.02 (0.648) 0.67
Wnt6 A_52_P415155 Wingless-related MMTV integration site 6 NM_009526 0.91 (0.063) 0.28
Genes are sorted based on gene name. The PCR array was performed once. Gene names in bold indicate significant change as measured
by qPCR (see Fig. 3).
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levels in Europeans are not as low as 12% of those in the US.
Consequences of a low intake, however, are obvious from
the well-known increase in cancer incidence in selenium-
deficient areas [33] and the decrease in cancer incidence by
selenium supplementation only in groups entering respec-
tive studies with a low selenium status [34].
Transcripts of SelW, GPx1, SelH, and SelM responded
significantly to selenium as measured by both microarray
analysis and qPCR. Although the response of GPx1 was
expected, the in vivo response of the other genes had so far
been poorly (SelW) or not at all documented (SelH and
SelM). The observed fall in SelW expression is consistent
with the previously observed almost complete loss in SelW
RNA expression in the colon of severely selenium-deficient
rats [35] fed a diet containing 1/10 of the Se content
in the deficient diet fed in this study. Moreover, SelW
mRNA expression strongly decreased in brain and testes of
SelP knockout mice [36] and increased in skeletal muscle of
rats fed selenium in a range from 0 to 4 mg/kg diet [37].
Taken together, these data confirm the high sensitivity of
SelW to selenium status. Additionally, we show here that
expression of SelH, and SelM in the murine colon was
also highly sensitive and this novel observation deserves
further evaluation, especially in view of their largely unknown
functions.
As selenoprotein expression is regulated both at a trans-
lational level and at the level of RNA stability [8, 38–40], thus
assessment of selenoprotein RNA levels in response to
changes in selenium supply provides information on RNA
degradation and on the hierarchy of selenoproteins. To date,
the mechanisms behind the hierarchical response of all
selenoproteins to dietary selenium remain unclear. The
tRNA[ser]sec plays a key role in this process. It is modified
post-transcriptionally at two bases and one ribose moiety in
the anticodon loop: A37 is modified to N6-isopentenylade-
nosine (i6A), U34 is methylated to methylcarboxyl-50-
methyluridine (mcm5U) and further methylated at the
ribosyl residue resulting in mcm5Um, also called Um34
(reviewed in [41]). Um34 formation is increased with
increasing selenium [42] and Um34 is responsible for the
synthesis of so-called stress-response selenoproteins such as
GPx1, GPx3, SelX (MsrB1), SelT, SelH, SelM, SelV, TrxR2,
and SelW in murine liver [43, 44]. The tRNA[ser]sec lacking
the 20-methylribose at position 34 (mcm5U) is responsible
for the synthesis of housekeeping selenoproteins (such as
TrxR1 and TrxR3) [44]. The observed sensitivity of SelW,
GPx1, SelH and SelM to selenium deprivation suggests that
the synthesis of these enzymes depends on the tRNA[ser]sec
methylation in the colon in a similar way as in the liver. An
absence or intermediate response to selenium was observed
for GPx2, GPx4, SelP, and Sep15, suggesting that their
synthesis was partially dependent on Um34 also in the
colon. A more complex response was observed for the
thioredoxin reductase genes that showed no response by
microarray, as expected from their housekeeping function,
but a moderate response when assessed by qPCR. The
dependency of the remaining selenoproteins (SPS2, SelK,
SelS, SelI, Dio1) on Um34 has not been investigated so far.
Contrary to the previous observations of an effect on
growth arrest and apoptosis in animals fed various selenium
compounds [10–12, 45], no striking effects on these path-
ways were observed in the present report. This could reflect
the fact that substantially higher doses of selenium than
here were used in the previous studies. Interestingly, five of
the top 15 regulated pathways are involved in protein
biosynthesis, indicating a striking effect of selenium on
protein biosynthesis in the colon. The net effect of selenium
deficiency on protein biosynthesis is not clear since some
genes are down-regulated and others up-regulated.
However, consistent with this observation, the protein
biosynthesis pathway was recently shown to be regulated by
selenium supplementation in human lymphocytes too [15].
The comparable findings in two different organs in two
different species identify protein synthesis as a pathway that
is particularly sensitive to selenium availability. Whether
selenoproteins are involved in the regulation of protein
synthesis is not known, but SelW [46], SelH [47], and SelM
[48] belong to the redoxin family of selenoproteins, which
contain a thioredoxin-like fold and a CXXU motif, indicating
a redox function. SelW is localized in the cytosol and has
been identified as 14-3-3-binding partner [46, 49]. SelH is
mainly localized in the nucleoli [47], a site for rRNA
biosynthesis and modification [50]. It further has redox-
responsive DNA-binding properties and can regulate genes
that respond to changes in the redox status [51]. SelM and
SelS/VIMP, for VCP/p97-interacting membrane protein
[52], are localized in the endoplasmic reticulum, the site for
protein folding and quality control [53]. They might act as
chaperones and prevent protein misfolding. A putative
redox-regulating capacity of all four above-mentioned sele-
noproteins influencing translational activity needs further
evaluation.
Interestingly, the number of selenium-responsive genes
in the Wnt pathway was surprisingly high. Wnt-inhibitory
factors and GSK3b, were down-regulated, whereas Wnt
receptors and the co-receptor (LRP), the stimulatory factors
Dvl, b-catenin and TCF/LEF, as well as b-catenin targets, the
cell type specific differentiation factor pitx2 [54] and c-myc
[55], were up-regulated the former at least in qPCR (Fig. 4).
By changing the expression of these genes, the predicted net
effect of selenium deficiency would be to slightly stimulate
the Wnt pathway, hence predisposing the tissue to further
Wnt-stimulating agents ultimately leading to carcinogen-
esis. Recently, Wnt signalling has been linked to the mTOR
pathway [56], in which mTOR functions as a central regu-
lator of cell growth [57]. To elucidate whether and how
selenium regulates this complex network is a challenging
future task.
Selenium deficiency decreased the expression of Smad4
and STAT3 as observed in several cytokine pathways
(inflammation) and in the Delta-Notch pathway (carcino-
genesis). STATs are activated in response to many different
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cytokines and growth factors, whereas Smads transfer TGFb
signals. TGFb is a multifunctional growth factor and has
both tumour suppressor and tumour-promoting activities.
TGFb-mediated cell growth is triggered by Smad 2, 3, and 4,
which are part of the transcriptional repression complexes,
e.g. at the c-myc promoter. Since TGFb serves as tumour
suppressor in the normal intestinal epithelium, the down-
regulation of signal transducers such as Smad4 in selenium
deficiency might contribute to the generally higher cancer
risk in selenium deficiency. How and if, however, selenium
interferes with these pathways awaits further investigations.
In conclusion, feeding a marginally selenium-deficient
diet to mice led to a change in the global gene expression in
the colon. Expression of four selenoproteins (SelW, H, M,
and GPx1) dramatically decreased in selenium-deficient
status, suggesting that these selenoproteins rank low in the
selenoprotein hierarchy in the colon. Interestingly, this
correlates with the dependence of synthesis of these sele-
noproteins on Um34, highlighting the role of this methy-
lated tRNA in the hierarchy. These four selenoproteins
should be further investigated as markers for selenium
status. Two of them are directly, or indirectly, involved in the
regulation of protein folding (SelM, SelW via 14-3-3) and
may contribute to the change in genes functioning in
protein biosynthesis, which was the pathway most signifi-
cantly affected by selenium intake. Low selenium intake also
modulated cancer-relevant pathways, such as the Wnt,
mTOR, and TGF-pathways, and this may contribute to the
higher susceptibility to colon carcinogenesis in a selenium-
deficient status.
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